Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
23.05. | CardiaWave has positive 12-month Valvosoft results | ||
23.05. | Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent | ||
22.05. | Medtronic has a new Cardiovascular, CST leaders after longtime exec departs | ||
22.05. | TriCares reports positive first-in-human tricuspid valve results | ||
22.05. | Endiatx has a new CEO leading the PillBot developer | ||
22.05. | Data supports next-gen Meril heart valve replacement tech | ||
22.05. | Auxilium Biotechnologies launches pivotal trial for NeuroSpan Bridge implant | ||
22.05. | Boston Scientific Acurate neo2 fails to meet non-inferiority in study | ||
22.05. | Embecta eyes shift from insulin delivery to broader medical supplies focus | ||
22.05. | Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon | ||
22.05. | Edwards highlights cost savings, improved outcomes with prompt intervention for aortic stenosis | ||
22.05. | Sequel MedTech to pair automated insulin delivery system with Abbott's future dual glucose-ketone sensor | ||
22.05. | Medtronic inks expanded distro deal for multi-parameter wearable vital sign monitor | ||
21.05. | Medtronic earns CE mark for redo TAVI procedure | ||
21.05. | Natus Neuro launches BrainWatch AI-driven, point-of-care EEG | ||
21.05. | Boston Scientific has positive real-world Acurate Prime TAVI data | ||
21.05. | Johnson & Johnson MedTech launches ultrasound catheter for imaging in cardiac ablation procedures | ||
21.05. | Onward reports more successful BCI implants | ||
21.05. | Route 92 Medical wins FDA nod for reperfusion system, reports positive study findings | ||
21.05. | Medtronic expects up to $350M tariff impact, will spin off Diabetes | ||
20.05. | Atia Vision can begin intraocular lens trial, FDA says | ||
20.05. | Inner Cosmos shares data for psychiatric BCI tech | ||
20.05. | Regeneron to acquire 23andMe for $256M, plans to continue consumer genetics services | ||
20.05. | Philips launches real-world study of low-dose X-ray in coronary procedures | ||
20.05. | Johnson & Johnson hit with $147M antitrust verdict |